(NASDAQ: QTRX) Quanterix's forecast annual revenue growth rate of 16.79% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 24.86%.
Quanterix's revenue in 2025 is $135,688,000.On average, 6 Wall Street analysts forecast QTRX's revenue for 2025 to be $5,290,503,843, with the lowest QTRX revenue forecast at $5,064,905,110, and the highest QTRX revenue forecast at $5,464,071,198. On average, 6 Wall Street analysts forecast QTRX's revenue for 2026 to be $7,295,265,042, with the lowest QTRX revenue forecast at $6,724,084,774, and the highest QTRX revenue forecast at $7,726,271,226.
In 2027, QTRX is forecast to generate $8,210,473,670 in revenue, with the lowest revenue forecast at $7,644,729,516 and the highest revenue forecast at $8,676,038,008.